A higher incidence of metastasis emerged in KRAS-mutated CRC patients, whose relapse pattern depends on the KRAS mutational status with down-regulation of p-MAPK signaling prompting and forming distant lung metastasis [45]. Here, KRAS is linked to colorectal carcinoma.